About us

Företrädesemission 29 januari -12 februari

I samband med pågående nyemission, med teckningsperiod 29 januari – 12 februari, har vi publicerat en teaser som sammanfattar nuläget och beskriver de spännande aktiviteter som pågår i Monivent. 


Board of Directors

Board of Directors

Mattias Carlsson - Chairman of the Board

Mattias Carlsson

Chairman of the Board

Mattias currently acts as Business Angel and Member of the Board in SME companies. He has 25 years experience in various roles from the technology industry, mainly Food, Pharma and Medical Device area, for both listed and unlisted companies. His last position was market area manager LifeScience for ÅF. Mattias holds M.Sc. degree in Chemical Engineering from Lunds University of Technology.

Shareholding in Monivent: 1 000 000 shares

Camilla Myhre Sandberg - Board Member

Camilla Myhre Sandberg

Board Member

Camilla has 21 years’ experience in life science and has a Cand. Scient degree in toxicology from the University of Oslo. She has a broad experience in business development and marketing and has previously worked at Dynal Biotech, GE Healthcare and BioLamina AB. Camilla  is currently CEO of Miris Holding AB and board member of NextCell Pharma AB.

Susanna Andreasson - Board Member

Susanna Andreasson

Board Member

Susanna has a background as Management Consultant at Montell & Partners with focus on strategi, M&A och organization. Today she has the role as Head of Corporate Development and M&A Manager at Consilium Safety Group. Susanna holds a B.Sc. in Industrial Engineering and Management and a M.Sc. in Supply Chain Management from Chalmers University of Technology.

Shareholding in Monivent: 66 536 shares